ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

CYTO Altamira Therapeutics Ltd

1,18
0,06 (5,36%)
24 Jun 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Altamira Therapeutics Ltd CYTO NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,06 5,36% 1,18 18:49:44
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
1,11 1,11 1,20 1,18 1,12
mais cotações »

Notícias Recentes

Data Hora Fonte Título
20/06/202410:01GLOBEAltamira Therapeutics Highlights Newly Published Review..
28/05/202411:31GLOBEAltamira Therapeutics Provides Business Update
23/05/202409:47GLOBEAltamira Therapeutics Announces Dissemination of Positive..
01/05/202409:47GLOBEAltamira Therapeutics Announces Filing of Provisional Patent..
24/04/202409:47GLOBEAltamira Therapeutics Announces Publication of Positive..
10/04/202409:00GLOBEAltamira Therapeutics Provides Business Update, Reports Full..
04/04/202409:45GLOBEAltamira Therapeutics to Host Full Year 2023 Financial..
25/03/202409:47GLOBEAltamira Therapeutics Announces Collaboration with..
07/02/202410:47GLOBEAltamira Therapeutics’ Peptide-Based Delivery Platform Shown..
24/01/202410:47GLOBEAltamira Therapeutics Files Second Provisional Patent..
08/01/202410:47GLOBEAltamira Therapeutics to Present at 3rd Annual mRNA-Based..
29/12/202310:47GLOBEAltamira Therapeutics Regains Compliance with Nasdaq Minimum..
11/12/202310:00GLOBEAltamira Therapeutics Provides Investor and Business Update
05/12/202314:54GLOBEAltamira Therapeutics to Host Investor & Business Update..
29/11/202312:20GLOBEAltamira Therapeutics Regains Compliance with Nasdaq Minimum..
17/11/202311:04GLOBEAltamira Therapeutics Announces Partial Spin-Off of Bentrio®..
10/11/202310:47GLOBEAltamira Therapeutics Announces European Patent Office..
14/09/202309:47GLOBEAltamira Therapeutics Reports Additional Significant..
12/09/202308:30GLOBEAltamira Therapeutics Provides Business Update and First..
06/09/202309:47GLOBEAltamira Therapeutics to Host First Half 2023 Financial..
23/08/202309:47GLOBEAltamira Therapeutics to Present at H.C. Wainwright 25th..
20/07/202309:47GLOBEAltamira Therapeutics and Pharma Nordic Collaborate for..
17/07/202309:47GLOBEAltamira Therapeutics Announces Publication of Positive..
05/07/202309:47GLOBEAltamira Therapeutics Announces Collaboration with Heqet..